BBOT

BridgeBio Oncology
BBOT

53 hedge funds and large institutions have $756M invested in BridgeBio Oncology in 2025 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 4 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more funds holding in top 10

Funds holding in top 10: →

more capital invested

Capital invested by funds: $ → $

1.16% more ownership

Funds ownership: 71.74% → 72.9% (+1.2%)

0% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 12

Holders
53
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$7.12M
2
+$5.08M
3
+$4.98M
4
PBA
Paradigm Biocapital Advisors
New York
+$4.79M
5
HS
HighVista Strategies
Massachusetts
+$2.78M

Top Sellers

1
-$5.3M
2
-$3.33M
3
-$1.55M
4
SC
Stempoint Capital
New York
-$1.21M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$1.06M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
51
Bank of America
North Carolina
$50K
Rockefeller Capital Management
52
Rockefeller Capital Management
New York
$8.76K
Wells Fargo
53
Wells Fargo
California
$3.76K
SCM
54
Silverarc Capital Management
Massachusetts
–
CUAMC
55
China Universal Asset Management Company
China
–
FIA
56
FNY Investment Advisers
New York
–
1 2
3